Discover 2,440 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,440
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Location: Sherbrooke, New York NY, Pasadena MD, Camp Hill PA,
Sponsor: Apollo Therapeutics Ltd
Sex: All
Age: 18 - 65
Code: NCT07599813
Phase 2, Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
for
Pneumococcal Disease
Location: Baltimore MD, Columbia MD, East Syracuse NY,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT07629440
Phase 3, Recruiting
Health-E You Efficacy Trial for Male Adolescents
for
Sexually Transmitted Diseases, Sexual Health,
Location: New York NY, Philadelphia PA, Baltimore MD, Hershey PA,
Sponsor: Johns Hopkins University
Sex: Male
Age: 13 - 21
Code: NCT06525064
Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, Shirley NY, Farmington CT, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Brewer ME, Providence RI, West Islip NY, Stamford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07391774
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
for
Kidney Transplant Rejection
Location: Boston MA, The Bronx NY, New York NY, Baltimore MD,
Sponsor: Sanofi
Sex: All
Age: 18 - 70
Code: NCT07412470
Phase 2, Phase 3, Recruiting
Medication Treatment of ADHD in Pediatric Epilepsy
for
ADHD - Attention Deficit Disorder With Hyperactivity
Location: Baltimore MD
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Sex: All
Age: 6 - 17
Code: NCT07594652
Recruiting
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
for
Polymyalgia Rheumatica
Location: Sherbrooke, Trois-Rivieres, Willow Grove PA,
Sponsor: Sanofi
Sex: All
Age: 50+
Code: NCT07286214
Phase 3, Recruiting
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)
Sex: All
Age: 18 - 70+
Code: NCT04806282
Recruiting
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
for
Ovarian Cancer
Location: Philadelphia PA, Baltimore MD, Orlando FL,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT07546500
Phase 3, Recruiting
Crownlands Observing Progression With Neurons Study
for
Alzheimer s Disease, Mild Cognitive Impairment (MCI)
Location: Germantown MD
Sponsor: Crownlands
Sex: All
Age: 55+
Code: NCT07611396
Recruiting
Evaluation of [11C]ZTP-1 to Image PDE4B
for
Healthy
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)
Sex: All
Age: 18 - 70+
Code: NCT07625345
Phase 1, Recruiting
WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
for
Diabetes, Peripheral Neuropathy, Diabetic Foot,
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT05950659
Recruiting
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
for
Colo-rectal Cancer
Location: Baltimore MD, Richmond VA, Midlothian VA,
Sponsor: NSABP Foundation Inc
Sex: All
Age: 18+
Code: NCT07058012
Phase 2, Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
for
Diffuse Large B-cell Lymphoma (DLBCL)
Location: Boston MA, Stony Brook NY, New Brunswick NJ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091865
Phase 3, Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: New York NY, The Bronx NY, Hackensack NJ, Livingston NJ,
Sponsor: Rapport Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT07563881
Phase 3, Recruiting
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
for
Gonorrhea, Chlamydia, Syphilis,
Location: New York NY, Baltimore MD, Washington D.C. DC,
Sponsor: Westat
Sex: Female
Age: 13 - 29
Code: NCT06738407
Phase 4, Recruiting
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
for
Recurrent Glioblastoma,
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Sex: All
Age: 18 - 70+
Code: NCT07416188
Phase 1, Phase 2, Recruiting
Resilience Among Individuals With Opioid Use Disorder
for
Opioid Use Disorder
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT06954402
Recruiting
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia